We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$36B
AUM Growth
+$4.16B
(+13%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
1,767
New
125
Increased
1,085
Reduced
387
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
Apple
AAPL
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
Tesla
TSLA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$61.1M |
| 2 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$51.8M |
| 3 |
Invesco Aerospace & Defense ETF
PPA
|
+$38.3M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$37.5M |
| 5 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Communication Services | 10.86% |
| 3 | Consumer Discretionary | 9.43% |
| 4 | Healthcare | 6.67% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
RPM International
RPM
$14.7B
| $92.6K | ﹤0.01% |
890
+30
| +3% | +$3.25K |
|
1277
10x Genomics
TXG
$7.52B
| $92.3K | ﹤0.01% |
5,660
+1,237
| +28% | +$18.7K |
|
1278
COPT Defense Properties
CDP
$4.19B
| $91.7K | ﹤0.01% |
3,300
+827
| +33% | +$23.8K |
|
1279
Banco Santander Chile
BSAC
$16B
| $91.5K | ﹤0.01% |
2,940
+167
| +6% | +$4.87K |
|
|
SION
1280
Sionna Therapeutics
SION
$283M
| $89.2K | ﹤0.01% |
+2,169
| New | +$82.2K |
|
1281
Syndax Pharmaceuticals
SNDX
$1.77B
| $88.7K | ﹤0.01% |
4,223
+893
| +27% | +$15.6K |
|
1282
Cerence
CRNC
$391M
| $88.6K | ﹤0.01% |
8,289
+685
| +9% | +$7.53K |
|
1283
Vericel Corp
VCEL
$2.29B
| $88.5K | ﹤0.01% |
2,458
+507
| +26% | +$18.6K |
|
1284
Harrow
HROW
$1.48B
| $88.2K | ﹤0.01% |
1,800
+369
| +26% | +$15.5K |
|
1285
Stoke Therapeutics
STOK
$2.13B
| $88.1K | ﹤0.01% |
2,776
+658
| +31% | +$19.8K |
|
|
DVAX
1286
DELISTED
Dynavax Technologies
DVAX
| $87.8K | ﹤0.01% |
5,706
+1,172
| +26% | +$12.9K |
|
1287
Genmab
GMAB
$19.3B
| $87.5K | ﹤0.01% |
2,840
+1,219
| +75% | +$38K |
|
1288
Pharvaris
PHVS
$2.55B
| $86.4K | ﹤0.01% |
+3,113
| New | +$75K |
|
1289
ANI Pharmaceuticals
ANIP
$1.73B
| $86.1K | ﹤0.01% |
1,091
+253
| +30% | +$21.9K |
|
1290
AST SpaceMobile
ASTS
$22.3B
| $86.1K | ﹤0.01% |
+1,185
| New | +$84.6K |
|
1291
LXP Industrial Trust
LXP
$3.58B
| $85.6K | ﹤0.01% |
1,727
+431
| +33% | +$20.7K |
|
1292
BorgWarner
BWA
$14B
| $85.3K | ﹤0.01% |
1,893
-428
| -18% | -$18.7K |
|
1293
MannKind Corp
MNKD
$1.24B
| $84.6K | ﹤0.01% |
14,922
+3,060
| +26% | +$16.8K |
|
1294
Ares Capital
ARCC
$14.3B
| $84.2K | ﹤0.01% |
+4,160
| New | +$83.9K |
|
1295
Schwab US TIPS ETF
SCHP
$16.2B
| $84K | ﹤0.01% |
+3,170
| New | +$85K |
|
1296
Highwoods Properties
HIW
$3.46B
| $81.6K | ﹤0.01% |
3,159
+797
| +34% | +$22.5K |
|
1297
NOV
NOV
$7.45B
| $80.2K | ﹤0.01% |
5,132
-1,606
| -24% | -$23.8K |
|
1298
Santander
BSBR
$43.1B
| $80.2K | ﹤0.01% |
13,126
| – | – |
|
1299
DraftKings
DKNG
$12.7B
| $80.1K | ﹤0.01% |
2,323
-6,692
| -74% | -$220K |
|
1300
BioCryst Pharmaceuticals
BCRX
$2.71B
| $79.8K | ﹤0.01% |
10,231
+2,115
| +26% | +$15.3K |
|
Similar funds
Mirae Asset Global Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Mirae Asset Global Investments held 1,767 positions worth $36B, up 13% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments deployed $3.25B of net new capital in Q4 2025, opening 125 new positions and adding to 1,085 existing holdings. Its largest new stake was iShares Biotechnology ETF: 195,308 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $61.1M trimmed.
- Mirae Asset Global Investments's largest Q4 2025 buy was iShares Biotechnology ETF: 195,308 shares worth $33M.
- Mirae Asset Global Investments added most to NVIDIA in Q4 2025, an estimated $315M increase.
- Mirae Asset Global Investments's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $61.1M.
- Mirae Asset Global Investments fully exited Invesco Aerospace & Defense ETF in Q4 2025, selling an estimated $38.3M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $36B portfolio in Q4 2025.
- Mirae Asset Global Investments opened 125 new positions and closed 124 in Q4 2025.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $36B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.